Purchase Order 36C77025P0219

Award Date 7/2/25
Potential Completion Date 7/15/25
Potential Value $97K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Burbank, CA 91504, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
12
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,318.73 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 270 tablets of Sevelamer Carbonate 800 mg, a medication used to manage high phosphorus levels in patients with chronic kidney disease. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,376.79, is for the delivery of Sevelamer Carbonate 800 mg tablets in unit doses of 50s. The contract has a completion date of December 11, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This firm fixed-price purchase order was awarded to Pharmacy Buying Association, Inc. (DBA PBA Health), a small business prime contractor, by the Department of Veterans Affairs (VA) Network Contracting Office 15, CMOP Division. The $302,937.60 contract provides Sevelamer Carbonate 800mg tablets to multiple VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the country, supporting the VA's mission to provide pharmaceutical products and medical supplies for veteran healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,158.43, is for the supply of sevelamer carbonate 800 mg tablets. The contract has an ultimate completion date of January 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,550.32 firm fixed-price delivery order is for the supply of sevelamer hydrochloride 800 mg tablets, a medication used to treat certain kidney conditions. The contract has an ultimate completion date of March 10, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sevelamer Carbonate 800 mg tablets, a medication used to treat certain health conditions. The contract has a ceiling value of $4,170 and a period of performance through February 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated....
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,394.11, is for the delivery of sevelamer carbonate 800 mg tablets to support military healthcare programs. This is a delivery order contract with a firm fixed price pricing type, with a period of performance ending on January 2, 2024. The contract was awarded on December 29, 2023 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $4,088.59 contract is for the supply of 4565091271 - Sevelamer HCL 800 mg Tablets, 180 count, with a period of performance through July 9, 2024. The contract is not designated as a set-aside and was awarded as part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,438.91, is for the delivery of sevelamer carbonate 800 mg tablets. It is a firm fixed-price delivery order with a completion date of January 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a for-profit organization in the System for Award Management...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a $73,920 firm-fixed-price purchase order contract to Golden State Medical Supply, Inc., a small business pharmaceutical manufacturer and distributor based in Camarillo, California. The contract is for the delivery of 2,880 bottles of Sevelamer Carbonate 800mg tablets and 2,112 boxes of Sumatriptan 6mg/0.5mL injection syringes to the VA's Central Pharmacy Operations (CMOP) facility in Leavenworth, Kansas. This...

This federal contract award, valued at $97,356.00, was issued by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 15 (VISN 15), to the small business prime contractor Bryant Ranch Prepack Inc. located in Burbank, California. The contract is for the delivery of 2,928 bottles of 270 sevelamer carbonate 800mg tablets to the VA's Consolidated Mail Outpatient Pharmacy (CMOP) facility in Chelmsford, Massachusetts. This requirement was originally posted as a Request for Quotation (RFQ 36C77025Q0182) and designated as a total small business set-aside. The sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis. The contract has a firm fixed-price structure and a period of performance through July 15, 2025.

Generated 7/3/25, 2:51 PM